These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


301 related items for PubMed ID: 400003

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Experiences with monocomponent insulin].
    Fagerberg SE, Gamstedt A.
    Lakartidningen; 1976 Nov 17; 73(47):4097-9. PubMed ID: 994601
    [No Abstract] [Full Text] [Related]

  • 50. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ, Al-Khateeb SF, Di Mario U, Feek CM, Gray RS, Edmond B, Duncan LJ.
    Clin Exp Immunol; 1977 Oct 17; 30(1):16-21. PubMed ID: 606435
    [Abstract] [Full Text] [Related]

  • 51. A method for determination of anti-insulin antibodies in the plasma of insulin-treated diabetics.
    Sekso M, Resetić J, Riznar V, Solter M.
    Acta Med Iugosl; 1978 Oct 17; 32(2):125-34. PubMed ID: 665291
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Treatment with monocomponent semi-lente insulin in diabetes of difficult compensation].
    Barbero L, Gamba S, Zanno C, Regis G, Bruni B.
    Minerva Med; 1978 Apr 30; 69(21):1437-42. PubMed ID: 683547
    [Abstract] [Full Text] [Related]

  • 54. [Factors affecting the antigenicity of exogenous insulin in diabetics].
    Penchev II, Taneva T, Ditsov S, Andreev D.
    Vutr Boles; 1985 Apr 30; 24(1):113-9. PubMed ID: 3895740
    [Abstract] [Full Text] [Related]

  • 55. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
    Bruni KB, Neirotti R, Albonico G, Gamba S, Regis G, D'Adda A, Soldano E, Bruni B.
    Ann Osp Maria Vittoria Torino; 1976 Apr 30; 19(16):7-26. PubMed ID: 1027349
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Clinical evaluation of the mono-peak porcine and bovine insulin preparations, Maxirapid and Lente].
    Sroczyński J, Pietraszek F, Bresler M, Kuleszyńska G.
    Pol Tyg Lek; 1986 Mar 17; 41(11):339-42. PubMed ID: 3520515
    [No Abstract] [Full Text] [Related]

  • 58. [Serum levels of insulin-binding antibodies in diabetic children treated with monocomponent insulin].
    Symonides-Lawecka A, Ludwiczak H, Rogala H, Lawecki J, Czyzyk A.
    Pol Tyg Lek; 1974 Apr 22; 29(16):641-3. PubMed ID: 4827230
    [No Abstract] [Full Text] [Related]

  • 59. Human insulin.
    Roberts RJ.
    Iowa Med; 1984 Mar 22; 74(3):116-8. PubMed ID: 6373658
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.